Passion and Understanding: Essential for Rare Disease Clinical Trials

Patient-Centric Trial Design and Execution

Rare disease clinical trials pose unique challenges, such as recruiting patients from a limited and widely scattered patient pool and addressing travel considerations for patients with limited mobility.

In the latest Pharma’s Almanac article, Juliet Moritz, Senior Vice President, Strategic Solutions and Patient Centricity, Ergomed Clinical Research, outlines Ergomed’s strategy for significantly reducing burdens in rare disease clinical trials. This strategy is centered on deep expertise and a proactive, personalized approach to clinical trial preparation and execution.

Key learnings:

  • How to minimize patient and site burdens
  • Creating trial designs that meet regulatory restrictions
  • Maintaining a personal, patient-centric approach
  • Navigating diverse healthcare systems globally

Read the “Passion and Understanding: Essentials for Rare Disease Clinical Trials” article to discover how Ergomed navigates the complexities of rare disease clinical trials.

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.